The pharmacologic management of multiple myeloma in older adults-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The pharmacologic management of multiple myeloma in older adults

Published:2019-02-20 Issue:7 Volume:20 Page:887-902
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Dempsey Jessica L.¹,Johns Andrew²,Rosko Ashley E.³,Lazarus Hillard M.⁴

Affiliation:

1. Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, USA

2. Department of Internal Medicine, The Ohio State University, Columbus, OH, USA

3. Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA

4. Department of Medicine, Division of Hematology and Oncology, Case Western Reserve University, Cleveland, OH, USA

Funder

not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2019.1577822

Reference136 articles.

1. Multiple Myeloma

2. SEER. Cancer Stat Facts: myeloma. National Cancer Institute cited; Available from: https://seer.cancer.gov/statfacts/html/mulmy.html

3. Frailty in elderly people

4. Cardiovascular complications of multiple myeloma in the elderly

5. miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of chemotherapy-related adverse drug reactions among multiple myeloma patients at Kenyatta national hospital;Journal of Oncology Pharmacy Practice;2024-09-05

2. A comprehensive review of the PTEN/PI3K/Akt axis in multiple myeloma: From molecular interactions to potential therapeutic targets;Pathology - Research and Practice;2024-08

3. Comorbidities and survival of multiple myeloma patients diagnosed in Finland between 2000 and 2021;Annals of Hematology;2024-07-04

4. The Effect of Age and Other Patient Characteristics on Outcomes Among Nontransplanted Patients Who Were Treated With First-Line Lenalidomide, Bortezomib, and Dexamethasone: Results From the ConnectⓇ MM Registry;Clinical Lymphoma Myeloma and Leukemia;2024-06

5. Multiple Myeloma Drug Therapy: Considerations on Effectiveness and Safety;Interdisciplinary Cancer Research;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3